Literature DB >> 15189107

Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.

John M Kane1.   

Abstract

Both conventional and atypical antipsychotics cause an up-regulation of dopamine-2 receptors and have been associated with tardive dyskinesia. Studies of adult and elderly subjects have shown a greater incidence of tardive dyskinesia among patients who were administered conventional antipsychotic drugs than those given atypical antipsychotic drugs. This article will review studies of the prevalence and incidence of tardive dyskinesia in patients taking antipsychotic agents.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15189107

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


  21 in total

1.  Pharmacogenetics in mood disorder.

Authors:  Charles U Nnadi; Joseph F Goldberg; Anil K Malhotra
Journal:  Curr Opin Psychiatry       Date:  2005-01       Impact factor: 4.741

2.  Possible association between DBH 19 bp insertion/deletion polymorphism and clinical symptoms in schizophrenia with tardive dyskinesia.

Authors:  Li Hui; Mei Han; Xu Feng Huang; Min Jie Ye; Ke Zheng; Jin Cai He; Meng Han Lv; Bao Hua Zhang; Jair C Soares; Xiang Yang Zhang
Journal:  J Neural Transm (Vienna)       Date:  2014-10-22       Impact factor: 3.575

3.  Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Markus Mittendorf; Frank M Theisen; Karin Wolf-Ostermann; Phillip Grant; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-04-28       Impact factor: 4.785

Review 4.  [Antipsychotic-induced tardive syndromes].

Authors:  W Wolfgang Fleischhacker; Alex Hofer; Christian Jagsch; Walter Pirker; Georg Psota; Hans Rittmannsberger; Klaus Seppi
Journal:  Neuropsychiatr       Date:  2016-08-31

5.  Low-Dose Risperidone-Induced Oculogyric Crises in an Adolescent Male with Autism, Tourette's and Developmental Delay.

Authors:  Tamara Masliyah; Yasser Ad-Dab'bagh
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-08

Review 6.  Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Authors:  Carlos Estevez-Fraga; Paul Zeun; Jose Luis López-Sendón Moreno
Journal:  Drugs Aging       Date:  2018-11       Impact factor: 3.923

Review 7.  Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.

Authors:  Keming Gao; David E Kemp; Stephen J Ganocy; Prashant Gajwani; Guohua Xia; Joseph R Calabrese
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153

8.  Comparative effectiveness research for antipsychotic medications: how much is enough?

Authors:  David O Meltzer; Anirban Basu; Herbert Y Meltzer
Journal:  Health Aff (Millwood)       Date:  2009-07-21       Impact factor: 6.301

9.  Tying comparative effectiveness information to decision-making and the future of comparative effectiveness research designs: the case for antipsychotic drugs.

Authors:  Anirban Basu; Herbert Y Meltzer
Journal:  J Comp Eff Res       Date:  2012-03       Impact factor: 1.744

10.  Comparing tolerability of olanzapine in schizophrenia and affective disorders: a meta-analysis.

Authors:  Hoda Moteshafi; Simon Zhornitsky; Sarah Brunelle; Emmanuel Stip
Journal:  Drug Saf       Date:  2012-10-01       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.